Technology | PET Imaging | December 05, 2018

Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET

Artificial intelligence-based technology allows faster PET scans while enhancing image quality

Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET

December 5, 2018 — Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle Medical also recently secured approval to affix the CE Mark on SubtlePET to begin marketing in the European Economic Area without restrictions.

SubtlePET’s artificial intelligence (AI)-powered technology allows hospitals and imaging centers to enhance images from faster positron emission tomography (PET) scans, leading to an improved patient experience during nuclear imaging procedures, while boosting exam throughput and provider profitability. SubtlePET is currently in pilot clinical use in multiple university hospitals and imaging centers in the U.S. and abroad.

“Focusing Subtle Medical's SubtlePET AI platform on faster image acquisition, we have been able to dramatically increase PET scan efficiency and provide a superior patient experience. SubtlePET  technology allows us to scan a patient four times faster than normal, yet maintain equal image quality, not otherwise impacting work flow,” said Michael Brant-Zawadzki, M.D., FACR, Hoag Hospital, Newport Beach, Calif. “This creates immediate ROI [return on investment] benefit for our hospital and a compelling value proposition. I’m looking forward to seeing more groundbreaking technology from the Subtle team.”

Subtle Medical’s AI solution:

  • Enables completion of more exams in a day compared to conventional PET imaging without the need for capital expenditures;
  • Reduces patient time in the scanner; and
  • Helps hospitals and imaging centers enhance their bottom line in today’s competitive healthcare environment.  

The company’s technology utilizes deep learning algorithms that integrate seamlessly with any OEM scanner and picture archiving and communication system (PACS) to enhance images during acquisition, without any interruption or alteration in the imaging specialists’ workflow.  SubtlePET delivers a significant improvement in the image quality of noisy images resulting from shorter scans, which is particularly beneficial for children and those undergoing repeat PET exams.

SubtlePET is the first product in Subtle Medical’s growing portfolio of new AI technologies to receive FDA clearance. The company is developing additional products to be submitted for FDA clearance.  A second product currently undergoing clinical evaluation is SubtleMR, which allows imaging centers to significantly accelerate magnetic resonance imaging (MRI) scans using the company’s AI solutions. SubtleGAD is also being developed to reduce gadolinium dosage during imaging procedures.

For more information: www.subtlemedical.com

Related Content

Videos | Artificial Intelligence | November 07, 2019
Piotr Slomka explains how his team at Cedars-Sinai is working on intelligent patient risk prediction algorithms...
AI Could Use EKG Data to Measure Patient's Overall Health Status

Image courtesy of iStock

News | Artificial Intelligence | August 29, 2019
In the near future, doctors may be able to apply artificial intelligence (AI) to electrocardiogram data in order to...
Half of Hospital Decision Makers Plan to Invest in AI by 2021
News | Artificial Intelligence | August 08, 2019
A recent study conducted by Olive AI explores how hospital leaders are responding to the imperative to drive efficiency...
Artificial Intelligence Solution Improves Clinical Trial Recruitment

A nurse examines a patient in the Emergency Department of Cincinnati Children’s, where researchers successfully tested artificial intelligence-based technology to improve patient recruitment for clinical trials. Researchers report test results in the journal JMIR Medical Informatics. Image courtesy of Cincinnati Children’s.

News | Artificial Intelligence | July 31, 2019
Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that...

An example of AI-assisted automation developed by TomTec, where a deep learning algorithm automatically marks the myocardial borders and performs auto quantification This removes time consuming tasks to free up the operator to spend more time with patients and helps make exams more reproducible.

Feature | Artificial Intelligence | July 26, 2019
Intelligent software solutions (aka...
vRad Presents AI Model to Assess Probability of Aortic Dissection
News | Artificial Intelligence | July 01, 2019
vRad (Virtual Radiologic), a Mednax company recently made a scientific presentation, “Screening for Aortic Dissection...
Videos | Artificial Intelligence | June 28, 2019
This is a quick example of how artificial intelligence (AI) is being integrated on the back end of cardiac ultrasound
Overlay Init